Immunology of the Acquired Immunodeficiency Syndrome

Total Page:16

File Type:pdf, Size:1020Kb

Immunology of the Acquired Immunodeficiency Syndrome Henry Ford Hospital Medical Journal Volume 32 Number 2 Article 6 6-1984 Immunology of the Acquired Immunodeficiency Syndrome Patrick W. McLaughlin Carl B. Lauter Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation McLaughlin, Patrick W. and Lauter, Carl B. (1984) "Immunology of the Acquired Immunodeficiency Syndrome," Henry Ford Hospital Medical Journal : Vol. 32 : No. 2 , 107-115. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol32/iss2/6 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. Henry Ford Hospital Med J Vol. 32, No. 2, 1984 Immunology of the Acquired Immunodeficiency Syndrome Patrick W. McLaughlin, MD* and Carl B. Lauter, MD** The Acquired Immunodeficiency Syndrome (AIDS) first known to cause immunodeficiency. Simian AIDS, an recognized in 1981, has been extensively studied, and animal model of virus-induced immunodeficiency, is the most recent studies have demonstrated that its also discussed. Recommendations are made regarding defects extend well beyond the apparent deficient the interpretation and limitations of immune testing in cell-mediated immunity to include humoral immunity, AIDS, includinga discussion of how apparently healthy autoimmunity, and abnormal immunoregulation. The homosexuals and groups at risk develop an immu­ recent discovery ofa retrovirus, HTLV III, as a possible nologic profile which mimics that of patients with AIDS. etiologic agent is discussed in relation to other viruses J\r\ce late 1981, an unexpected outbreak of oppor­ The immune system has "surveillance" functions to tunistic infections and unusual neoplasms has been protect humans (and other vertebrates) from infections noted, described, and studied (1-4). This outbreak ap­ and cancer. Multipotential stem cells arise during em- pears to have had its onset in the United States in bryogenesis and develop further into two major popu­ 1978-1979. The affected patients lacked the usual con­ lations of lymphoid stem cells (5-8). One ofthese, pre-T genital or acquired immunosuppressive background cells, leaves the bone marrow, enters the epithelial illnesses that would be expected to predispose to such thymus, and matures there into mature T-cells under infections as Pneumocystis pneumonia and such neo­ the influence of local thymic hormones. Mature T-cells plasms as disseminated aggressive Kaposi's sarcoma. leave the thymus and populate the paracortical and The term "acquired immunodeficiency syndrome" medullary areas of lymph nodes, the central regions of (AIDS) is partially inaccurate, since it does not really the periarterial lymphoid sheaths of the spleen, and differentiate the current syndrome from many known other sites. T-cells recognize foreign antigens and self acquired immunodeficiency states such as leukemia, because of receptors on their surfaces. This system is lymphoma, systemic lupus erythematosus, and mal­ genetically controlled. A variety of T-cell surface anti­ nutrition. In addition, exogenous factors such as gens can be identified using monoclonal antibodies, and treatment with corticosteroids and other immune these antibodies can define T-cell subpopulations (5). suppressing medications can cause acquired immu­ nodeficiency. Perhaps a more descriptive (albeit, more cumbersome) term could be the "idiopathic" acquired B-cells mature in the bone marrow of mammals. The immunodeficiency syndrome. This report will attempt cell membrane ofthese cells incorporates IgD and IgM, to summarize and review the immunologic abnormali­ and these serve as recognition units for antigen(s). ties that have been described in AIDS and its apparently After specific antigenic stimulation, B-celis, usually related disorders. We will also review such immu­ under the influence of helper T-cells, undergo blastic nologic data as are available in normal healthy controls transformation, proliferate, and differentiate further. and high-risk groups, eg, homosexual men, intra­ Diversification occurs, and the five classes of immu­ venous drug users, and hemophilia patients. noglobulins are produced and secreted. The B-cells mature further into plasma cells which secrete either IgG, IgM, IgA, IgD, or IgE in varying quantities. General Overview of the Immune System The immune system is complicated, and concepts of its ongins, functions, controls, and derangements are continuously changing. Newer tools, such as hybrid- Submitted for publication: May 29, 1984 oma-produced monoclonal antibodies to cell surface Accepted for publication: July 13, 1984 markers on lymphocytes and other effector cells have •Senior Resident, Internal Medicine, William Beaumont Hospital; Currently provided more information, yet raised more questions. Fellow, Hematology-Oncology, University of Michigan Medical Center; The simplified outline of the immune system which ••Chief of Medical Services, William Beaumont Hospital, and Associate Clinical Professor of Medicine, Wayne State University School of Medicine follows will serve as a ground for the discussion that Address reprint requests to Dr. Lauter, Department of Medicine, William follows. Beaumont Hospital, 3601 W. 13 Mile Road, Royal Oak, Ml 48072, 107 McLaughlin and Lauter T-cells recognize antigen(s) and a self marker, la, coded their surface of certain class II histocompatibility mol­ by the HLA-D region in the major histocompatibility ecules that are needed for the presentation of foreign system. This encounter results in the blastic transfor­ antigens. mation and proliferation of specific T-cell clones. B-cell activation cell division requires B-cell growth However, in contrast to the change described for the factor which is produced by T-cells and interleukin-1. B-cells, several T-cell subpopulations have specific Additional lymphokines, called B-cell differentiation functions, eg, memory, suppressor activity, helper factors, are then needed to stimulate the B-cells to a activity, cytotoxicity, and lymphokine production. A state where they can produce antibodies. number of lymphokines (soluble mediators or hor­ mones released by lymphocytes that influence other In the peripheral blood, approximately two thirds ofthe immune cells) have been identified, including inter­ circulating lymphocytes are T-cells, and one third are ferons, migration inhibiting factor (MIF), and transfer B-cells. Of the T-lymphocytes in the blood, approxi­ factor. mately two thirds are helper T-cells and one third suppressor T-cells, giving the "normal" helper-to- Monocyte-macrophages are involved in these pro­ suppressor ratio of approximately 1.2:2.2 in normal, cesses in at least two steps (7). Early on, these cells healthy adults (5). In other tissues, T-cells constitute encounter new antigens, "process" them, and present more than 75% of the lymphocytes in lymph and lymph them to wandering T- and B-cells. Once "activated" by nodes, and B-cells more than 75% of the lymphocytes in these antigens, the T- and B-cells undergo the changes the bone marrow. The proportion of T- and B- described earlier. Eventually, the lymphokines (eg, MIF lymphocytes in the spleen is approximately 50% of and others) released by these activated lymphocytes each. further influence the monocyte-macrophages to per­ form their effector functions in a more vigorous manner (turned on, "angry," activated macrophages). One such Immunologic Findings in AIDS specialized cell in the epidermis, the Langerhans cell, serves as the antigen-presenting cell in the skin. Other with Routine Screening Techniques types of these cells are found in important areas in the In view of the complexity of the immune system, the lymphoid tissues and organs. many tests available for use or abuse, and the need for accurate, timely, and cost-effective diagnostic tests in A review of the immune system organization requires patients at risk for AIDS, it is very important for clini­ more detailed mention of the chemical signals that cians to be aware of the office and laboratory clues that regulate cell growth and differentiation (8). A major can be readily obtained without a sophisticated immu­ lymphokine is interleukin-2, which was originally de nology laboratory. It should be reemphasized that AIDS scribed in the mid-1970s and named T-cell growth factor. is a syndrome; even with the most expensive tech­ Interleukin-2 is produced by T-cells, and it in turn stimu­ nology available today, the diagnosis cannot be made lates the division of T-cells. In addition, interleukin-2 with laboratory testing alone. stimulates T-cells to produce gamma (immune) inter­ Patients who meet the rigorous Centers for Disease feron which also serves as a lymphokine with several Control (CDC) criteria (2,3) for the diagnosis of AIDS defined important functions. Interleukin-2 seems to will almost invariably have evidence of cellular immu­ have a limited range of sources and targets. Only T-cells nodeficiency. Opportunistic infections with micro­ that are antigenically stimulated will respond to organisms (especially viral, fungal, mycobacterial, and interleukin-2. In contrast, interleukin-1 has a wide range parasitic) and/or the presence of certain tumors against of effects on non-lymphocytic cells which contribute to which cellular immunity (T-cell mediated
Recommended publications
  • Our Immune System (Children's Book)
    OurOur ImmuneImmune SystemSystem A story for children with primary immunodeficiency diseases Written by IMMUNE DEFICIENCY Sara LeBien FOUNDATION A note from the author The purpose of this book is to help young children who are immune deficient to better understand their immune system. What is a “B-cell,” a “T-cell,” an “immunoglobulin” or “IgG”? They hear doctors use these words, but what do they mean? With cheerful illustrations, Our Immune System explains how a normal immune system works and what treatments may be necessary when the system is deficient. In this second edition, a description of a new treatment has been included. I hope this book will enable these children and their families to explore together the immune system, and that it will help alleviate any confusion or fears they may have. Sara LeBien This book contains general medical information which cannot be applied safely to any individual case. Medical knowledge and practice can change rapidly. Therefore, this book should not be used as a substitute for professional medical advice. SECOND EDITION COPYRIGHT 1990, 2007 IMMUNE DEFICIENCY FOUNDATION Copyright 2007 by Immune Deficiency Foundation, USA. Readers may redistribute this article to other individuals for non-commercial use, provided that the text, html codes, and this notice remain intact and unaltered in any way. Our Immune System may not be resold, reprinted or redistributed for compensation of any kind without prior written permission from Immune Deficiency Foundation. If you have any questions about permission, please contact: Immune Deficiency Foundation, 40 West Chesapeake Avenue, Suite 308, Towson, MD 21204, USA; or by telephone at 1-800-296-4433.
    [Show full text]
  • Theory of an Immune System Retrovirus
    Proc. Nati. Acad. Sci. USA Vol. 83, pp. 9159-9163, December 1986 Medical Sciences Theory of an immune system retrovirus (human immunodeficiency virus/acquired immune deficiency syndrome) LEON N COOPER Physics Department and Center for Neural Science, Brown University, Providence, RI 02912 Contributed by Leon N Cooper, July 23, 1986 ABSTRACT Human immunodeficiency virus (HIV; for- initiates clonal expansion, sustained by interleukin 2 and y merly known as human T-cell lymphotropic virus type interferon. Ill/lymphadenopathy-associated virus, HTLV-Ill/LAV), the I first give a brief sketch of these events in a linked- retrovirus that infects T4-positive (helper) T cells of the interaction model in which it is assumed that antigen-specific immune system, has been implicated as the agent responsible T cells must interact with the B-cell-processed virus to for the acquired immune deficiency syndrome. In this paper, initiate clonal expansion (2). I then assume that virus-specific I contrast the growth of a "normal" virus with what I call an antibody is the major component ofimmune system response immune system retrovirus: a retrovirus that attacks the T4- that limits virus spread. As will be seen, the details of these positive T cells of the immune system. I show that remarkable assumptions do not affect the qualitative features of my interactions with other infections as well as strong virus conclusions. concentration dependence are general properties of immune Linked-Interaction Model for Clonal Expansion of Lympho- system retroviruses. Some of the consequences of these ideas cytes. Let X be the concentration of normal infecting virus are compared with observations.
    [Show full text]
  • Agammaglobulinemia Hypogammaglobulinemia Hereditary Disease Immunoglobulins
    Pediat. Res. 2: 72-84 (1968) Agammaglobulinemia hypogammaglobulinemia hereditary disease immunoglobulins Hereditary Alterations in the Immune Response: Coexistence of 'Agammaglobulinemia', Acquired Hypogammaglobulinemia and Selective Immunoglobulin Deficiency in a Sibship REBECCA H. BUCKLEY[75] and J. B. SIDBURY, Jr. Departments of Pediatrics, Microbiology and Immunology, Division of Immunology, Duke University School of Medicine, Durham, North Carolina, USA Extract A longitudinal immunologic study was conducted in a family in which an entire sibship of three males was unduly susceptible to infection. The oldest boy's history of repeated severe infections be- ginning in infancy and his marked deficiencies of all three major immunoglobulins were compatible with a clinical diagnosis of congenital 'agammaglobulinemia' (table I, fig. 1). Recurrent severe in- fections in the second boy did not begin until late childhood, and his serum abnormality involved deficiencies of only two of the major immunoglobulin fractions, IgG and IgM (table I, fig. 1). This phenotype of selective immunoglobulin deficiency is previously unreported. Serum concentrations of the three immunoglobulins in the youngest boy (who also had a late onset of repeated infection) were normal or elevated when he was first studied, but a marked decline in levels of each of these fractions was observed over a four-year period (table I, fig. 1). We could find no previous reports describing apparent congenital and acquired immunologic deficiencies in a sibship. Repeated infections and demonstrated specific immunologic unresponsiveness preceded gross ab- normalities in the total and fractional gamma globulin levels in both of the younger boys (tables II-IV). When the total immunoglobulin level in the second boy was 735 mg/100 ml, he failed to respond with a normal rise in titer after immunization with 'A' and 'B' blood group substances, diphtheria, tetanus, or Types I and II poliovaccines.
    [Show full text]
  • Ataxia Telangiectasia: a Diagnostic Challenge. Case Report
    case reports 2020; 6(2) https://doi.org/10.15446/cr.v6n2.83219 ATAXIA TELANGIECTASIA: A DIAGNOSTIC CHALLENGE. CASE REPORT Keywords: Ataxia Telangiectasia; Neurodegenerative Diseases; Cerebellar Ataxia; Spinocerebellar Degenerations; Telangiectasia. Palabras clave: Ataxia telangiectasia; Enfermedades neurodegenerativas; Ataxia cerebelosa; Degeneraciones espinocerebelosa; Telangiectasia. Natalia Martínez-Córdoba Universidad Militar Nueva Granada - Faculty of Medicine - Pediatric Neurology Research Group - Bogotá D.C. - Colombia. Hospital Militar Central - Pediatric Neurology Service - Bogotá D.C. - Colombia. Eugenia Espinosa-García Universidad Militar Nueva Granada - Faculty of Medicine - Pediatric Neurology Research Group - Bogotá D.C. - Colombia. Hospital Militar Central - Pediatric Neurology Service - Bogotá D.C. - Colombia. Universidad del Rosario - Medical School - Bogotá D.C. - Colombia. Corresponding author Natalia Martínez-Córdoba. Faculty of Medicine, Universidad Militar Nueva Granada. Bogotá D.C. Colombia. Email: [email protected]. Received: 28/10/2019 Accepted: 08/01/2020 case reports Vol. 6 No. 2: 109-17 110 RESUMEN ABSTRACT Introducción. La ataxia-telangiectasia (AT) es Introduction: Ataxia-telangiectasia (AT) is a un síndrome neurodegenerativo con baja inciden- neurodegenerative syndrome with low incidence cia y prevalencia mundial que es causado por una and prevalence worldwide, which is caused by a mutación del gen ATM, es de herencia autosó- mutation of the ATM gene. It is an autosomal re- mica recesiva y se asocia a mecanismos defec- cessive disorder that is associated with defective tuosos en la regeneración y reparación del ADN. cell regeneration and DNA repair mechanisms. It Este síndrome se caracteriza por la presencia de is characterized by progressive cerebellar atax- ataxia cerebelosa progresiva, movimientos ocula- ia, abnormal eye movements, oculocutaneous res anormales, telangiectasias oculocutáneas e telangiectasias and immunodeficiency.
    [Show full text]
  • Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
    Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck.
    [Show full text]
  • Neonatal Leukopenia and Thrombocytopenia
    Neonatal Leukopenia and Thrombocytopenia Vandy Black, M.D., M.Sc., FAAP March 3, 2016 April 14, 2011 Objecves • Summarize the differenHal diagnosis of leukopenia and/or thrombocytopenia in a neonate • Describe the iniHal steps in the evaluaon of a neonate with leukopenia and/or thrombocytopenia • Review treatment opHons for leukopenia and/ or thrombocytopenia in the NICU Clinical Case 1 • One day old male infant admiUed to the NICU for hypoglycemia and a sepsis rule out • Born at 38 weeks EGA by SVD • Birth weight 4 lbs 13 oz • Exam shows a small cephalohematoma; no dysmorphic features • PLT count 42K with an otherwise normal CBC Definions • Normal WBC count 9-30K at birth – Mean 18K • What is the ANC and ALC – <1000/mm3 is abnormal – 6-8% of infants in the NICU • Normal platelet count: 150-450,000/mm3 – Not age dependent – 22-35% of infants in the NICU have plts<150K Neutropenia Absolute neutrophil count <1500/mm3 Category ANC* InfecHon risk • Mild 1000-1500 None • Moderate 500-1000 Minimal • Severe <500 Moderate to Severe (Highest if <200) • Recurrent bacterial or fungal infecHons are the hallmark of symptomac neutropenia! • *ANC = WBC X % (PMNs + Bands) / 100 DefiniHon of Neutropenia Black and Maheshwari, Neoreviews 2009 How to Approach Cytopenias • Normal vs. abnormal (consider severity) • Malignant vs. non-malignant • Congenital vs. acquired • Is the paent symptomac • Transient, recurrent, cyclic, or persistent How to Approach Cytopenias • Adequate vs. decreased marrow reserve • Decreased producHon vs. increased destrucHon/sequestraon Decreased neutrophil/platelet producon • Primary – Malignancy/leukemia/marrow infiltraon – AplasHc anemia – Genec disorders • Secondary – InfecHous – Drug-induced – NutriHonal • B12, folate, copper Increased destrucHon/sequestraon • Immune-mediated • Drug-induced • Consumpon à Hypersplenism vs.
    [Show full text]
  • On Lupus, Vitamin D and Leukopenia
    r e v b r a s r e u m a t o l . 2 0 1 6;5 6(3):206–211 REVISTA BRASILEIRA DE REUMATOLOGIA w ww.reumatologia.com.br Original article On lupus, vitamin D and leukopenia ∗ Juliana A. Simioni, Flavia Heimovski, Thelma L. Skare Rheumatology Unit, Hospital Universitário Evangélico de Curitiba, Curitiba, PR, Brazil a r t i c l e i n f o a b s t r a c t Article history: Background: Immune regulation is among the noncalcemic effects of vitamin D. So, this Received 7 October 2014 vitamin may play a role in autoimmune diseases such as systemic lupus erythematosus Accepted 24 June 2015 (SLE). Available online 4 September 2015 Objectives: To study the prevalence of vitamin D deficiency in SLE and its association with clinical, serological and treatment profile as well as with disease activity. Keywords: Methods: Serum OH vitamin D3 levels were measured in 153 SLE patients and 85 controls. Data on clinical, serological and treatment profile of lupus patients were obtained through Systemic lupus erythematosus Vitamin D chart review. Blood cell count and SLEDAI (SLE disease activity index) were measured simul- Leukopenia taneously with vitamin D determination. Granulocytopenia Results: SLE patients have lower levels of vitamin D than controls (p = 0.03). In univariate analysis serum vitamin D was associated with leukopenia (p = 0.02), use of cyclophos- phamide (p = 0.007) and methotrexate (p = 0.03). A negative correlation was verified with prednisone dose (p = 0.003). No association was found with disease activity measured by SLEDAI (p = 0.88).
    [Show full text]
  • Acquired Immunodeficiency Syndrome (Aids)
    ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) What is Acquired Immunodeficiency Syndrome (AIDS)? AIDS stands for Acquired Immunodeficiency Syndrome. The term AIDS refers to an advanced stage of HIV infection. People are said to have AIDS when they have certain signs or symptoms specified in guidelines formulated by the U.S. Centers for Disease Control and Prevention (CDC). What causes AIDS? AIDS is caused by HIV (human immunodeficiency virus). By killing or damaging cells of the body's immune system, HIV progressively destroys the body's ability to fight infections and certain cancers. What are the signs and symptoms of AIDS? Symptoms of opportunistic infections common in people with AIDS include: • Coughing and shortness of breath • Seizures and lack of coordination • Difficult or painful swallowing • Mental symptoms such as confusion and forgetfulness • Severe and persistent diarrhea • Fever • Vision loss • Nausea, abdominal cramps, and vomiting • Weight loss and extreme fatigue • Severe headaches • Coma How is AIDS diagnosed? A diagnosis of AIDS is made by a physician using laboratory test results and clinical criteria such as AIDS indicator illnesses. Contact Number: STD Program, (302)-744-1050 Revised: 08/2013 Page 1 of 2 How is AIDS treated? Drugs approved for the treatment of HIV/AIDS fall into four classes, which are: 1. Nucleoside or nucleotide reverse transcriptase inhibitors. NRTIs work by blocking the enzyme reverse transcriptase, which helps the virus make DNA from its RNA. 2. Non-nucleoside reverse transcriptase inhibitors. NNRTIs work like the ones listed above. 3. Protease inhibitors. PIs work completely differently from those listed above. HIV produces an enzyme called protease (pronounced PRO-tee-ace) in the late stages of its reproduction.
    [Show full text]
  • Interactions of the Classical and Alternate Complement Pathway with Endotoxin Lipopolysaccharide EFFECT on PLATELETS and BLOOD COAGULATION
    Interactions of the Classical and Alternate Complement Pathway with Endotoxin Lipopolysaccharide EFFECT ON PLATELETS AND BLOOD COAGULATION Michael A. Kane, … , Joseph E. May, Michael M. Frank J Clin Invest. 1973;52(2):370-376. https://doi.org/10.1172/JCI107193. Research Article The contributions of the classical and alternate pathways of complement activation to the biological effects of endotoxin have been examined in the guinea pig, with particular reference to thrombocytopenia, leukopenia, and the development of the hypercoagulable state. Injection of endotoxin into normal guinea pigs led to a 95% fall in the level of circulating platelets within 15 min as well as a fall in circulating granulocytes. C4-deficient guinea pigs, known to have a complete block in the activity of the classical complement pathway, but with the alternate pathway intact, sustained no fall in platelets. The development of granulocytopenia proceeded normally. Endotoxin did activate the alternate complement pathway in C4D guinea pigs, as evidenced by the fall in C3-9 titers. With restoration of serum C4 levels, endotoxin- induced thrombocytopenia was observed in C4D animals. Thus, function of the classical complement pathway was an absolute requirement for the development of thrombocytopenia. Experiments performed in cobra venom factor (CVF)- treated normal guinea pigs, with normal levels of C1, C4, and C2, but with less than 1% of serum C3-9 demonstrated the importance of the late components in the development of thrombocytopenia but not leukopenia. C4-deficient guinea pigs had normal clotting times demonstrating that C4 was not required for normal clotting. In addition, development of the hypercoagulable state, evidenced by a marked shortening of the clotting […] Find the latest version: https://jci.me/107193/pdf Interactions of the Classical and Alternate Complement Pathway with Endotoxin Lipopolysaccharide EFFECT ON PLATELETS AND BLOOD COAGULATION MICHAEL A.
    [Show full text]
  • Blood and Immunity
    Chapter Ten BLOOD AND IMMUNITY Chapter Contents 10 Pretest Clinical Aspects of Immunity Blood Chapter Review Immunity Case Studies Word Parts Pertaining to Blood and Immunity Crossword Puzzle Clinical Aspects of Blood Objectives After study of this chapter you should be able to: 1. Describe the composition of the blood plasma. 7. Identify and use roots pertaining to blood 2. Describe and give the functions of the three types of chemistry. blood cells. 8. List and describe the major disorders of the blood. 3. Label pictures of the blood cells. 9. List and describe the major disorders of the 4. Explain the basis of blood types. immune system. 5. Define immunity and list the possible sources of 10. Describe the major tests used to study blood. immunity. 11. Interpret abbreviations used in blood studies. 6. Identify and use roots and suffixes pertaining to the 12. Analyse several case studies involving the blood. blood and immunity. Pretest 1. The scientific name for red blood cells 5. Substances produced by immune cells that is . counteract microorganisms and other foreign 2. The scientific name for white blood cells materials are called . is . 6. A deficiency of hemoglobin results in the disorder 3. Platelets, or thrombocytes, are involved in called . 7. A neoplasm involving overgrowth of white blood 4. The white blood cells active in adaptive immunity cells is called . are the . 225 226 ♦ PART THREE / Body Systems Other 1% Proteins 8% Plasma 55% Water 91% Whole blood Leukocytes and platelets Formed 0.9% elements 45% Erythrocytes 10 99.1% Figure 10-1 Composition of whole blood.
    [Show full text]
  • Immunodeficiency Disorders Ivan K
    Immunodeficiency Disorders Ivan K. Chinn, MD,*† Jordan S. Orange, MD, PhD‡x *Department of Pediatrics, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, TX †Center for Human Immunobiology, Texas Children’s Hospital, Houston, TX ‡Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY xNew York Presbyterian Morgan Stanley Children’s Hospital, New York, NY Education Gaps Immunodeficiencies are no longer considered rare conditions. Although susceptibility to infections has become well-recognized as a sign of most primary immunodeficiencies, some children will present with noninfectious manifestations that remain underappreciated and warrant evaluation by an immunologic specialist. Providers must also consider common secondary causes of immunodeficiency in children. Objectives After completing this article, readers should be able to: 1. Recognize infectious signs and symptoms of primary immunodeficiency that warrant screening and referral to a specialist. 2. Understand noninfectious signs and symptoms that should raise concern for primary immunodeficiency. 3. Determine appropriate testing for patients for whom immunodeficiency is suspected. AUTHOR DISCLOSURE Dr Chinn has disclosed that he is the recipient of a 4. Discuss the management of patients with primary immunodeficiency. Translational Research Program grant from the Jeffrey Modell Foundation. Dr Orange has 5. Appreciate secondary causes of immunodeficiency. disclosed that he is a consultant on the topic of therapeutic immunoglobulin for Shire, CSL Behring, and Grifols and that he serves on the scientific advisory board for ADMA Biologics. This commentary does contain a discussion of INTRODUCTION an unapproved/investigative use of a commercial product/device. Immunodeficiency disorders represent defects in the immune system that result in weakened or dysregulated immune defense.
    [Show full text]
  • Hyperimmunoglobulin E Syndrome: Genetics, Immunopathogenesis, Clinical Findings, And
    Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and TICLE R treatment modalities A Hassan Hashemi1,2, Masoumeh Mohebbi1,2, Shiva Mehravaran1,3, Mehdi Mazloumi2, Hamidreza Jahanbani-Ardakani4,5, Seyed-Hossein Abtahi4,5,6 1Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, 2Department of Ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, 4Isfahan Eye Research Center, Feiz Eye Hospital, Isfahan University of Medical Sciences, Isfahan, 5Isfahan Medical Students Research Center (IMSRC), Isfahan University of Medical Sciences, Isfahan, 6Department of Ophthalmology, Feiz Eye Hospital, 3 EVIEW Isfahan University of Medical Sciences, Isfahan, Iran, Department of Ophthalmology, Stein Eye Institute, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA R The hyperimmunoglobulin E syndromes (HIESs) are very rare immunodeficiency syndromes with multisystem involvement, including immune system, skeleton, connective tissue, and dentition. HIES are characterized by the classic triad of high serum levels of immunoglobulin E (IgE), recurrent staphylococcal cold skin abscess, and recurrent pneumonia with pneumatocele formation. Most cases of HIES are sporadic although can be inherited as autosomal dominant and autosomal recessive traits. A fundamental immunologic defect in HIES is not clearly elucidated but abnormal neutrophil chemotaxis due to decreased production or secretion of interferon γ has main role in the immunopathogenesis of syndrome, also distorted Th1/Th2 cytokine profile toward a Th2 bias contributes to the impaired cellular immunity and a specific pattern of infection susceptibility as well as atopic‑allergic constitution of syndrome. The ophthalmic manifestations of this disorder include conjunctivitis, keratitis, spontaneous corneal perforation, recurrent giant chalazia, extensive xanthelasma, tumors of the eyelid, strabismus, and bilateral keratoconus.
    [Show full text]